The pros and cons of phytoestrogens

Frontiers in Neuroendocrinology

Volumn 31, Issue 4, 2010, Pages 400-419

  Patisaul, Heather B ^a   Jefferson, Wendy ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Brain; Endocrine disruption; Equol; ER ; ER ; Estrogen; Genistein; Hypothalamus; Isoflavones; Soy

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; COUMESTROL; DAIDZEIN; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; FLAVONOID; FOLLITROPIN; GENISTEIN; ISOFLAVONE DERIVATIVE; ISOFLAVONOID; LUTEINIZING HORMONE; PHYTOESTROGEN; POLYPHENOL DERIVATIVE; RESVERATROL; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTIFICIAL MILK; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENDOCRINE DISEASE; ESTROGEN THERAPY; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FOOD COMPOSITION; GENE EXPRESSION; GYNECOLOGIC DISEASE; HEART DISEASE; HEART PROTECTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HOT FLUSH; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LORDOSIS; MENOPAUSAL SYNDROME; NEUROTOXICITY; NIGHT SWEAT; NONHUMAN; OOCYTE DEVELOPMENT; OVARY DEVELOPMENT; OVARY FUNCTION; OVULATION; PHYTOTOXICITY; PLACENTAL TRANSFER; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REPRODUCTIVE TOXICITY; REVIEW; RISK REDUCTION; SEX DIFFERENTIATION; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; SOYBEAN; SPONTANEOUS ABORTION; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; BREAST NEOPLASMS; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTORS; FEMALE; GENITALIA; HEART DISEASES; HUMANS; MALE; MENOPAUSE; MENSTRUAL CYCLE; MICE; OSTEOPOROSIS; PHYTOESTROGENS; PUBERTY; RATS; SEXUAL BEHAVIOR; SOYBEAN PROTEINS;

EID: 77957329762     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2010.03.003     Document Type: Review

References (308)

1. Adams N.R. Detection of the effects of phytoestrogens on sheep and cattle. J. Anim. Sci. 1995, 73:1509-1515.
2. Adams N.R. Organizational and activational effects of phytoestrogens on the reproductive tract of the ewe. Proc. Soc. Exp. Biol. Med. 1995, 208:87-91.
3. Adewale H.B., Jefferson W.N., Newbold R.R., Patisaul H.B. Neonatal Bisphenol-A exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin releasing hormone neurons. Biol. Reprod. 2009.
4. Adlercreutz H., Mazur W. Phyto-oestrogens and western diseases. Ann. Med. 1997, 29:95-120.
5. Adlercreutz H., Mousavi Y., Clark J., Höckersted K., Hämäläinen E.K., Wähälä K., Mäkelä T., Hase T. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 1992, 41:331-337.
6. Adlercreutz H., Fotsis T., Watanabe S., Lampe J., Wahala K., Makela T., Hase T. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev. 1994, 18:259-271.
7. Adlercreutz H., Yamada T., Wahala K., Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am. J. Obstet. Gynecol. 1999, 180:737-743.
8. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 2000, 60:1051-1059.
9. Aksglaede L., Sorensen K., Petersen J.H., Skakkebaek N.E., Juul A. Recent decline in age at breast development: the copenhagen puberty study. Pediatrics 2009, 123:e932-e939.
10. Anderson J.J., Ambrose W.W., Garner S.C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med. 1998, 217:345-350.
11. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H., Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 2000, 10:127-135.
12. Atkinson C., Warren R.M., Sala E., Dowsett M., Dunning A.M., Healey C.S., Runswick S., Day N.E., Bingham S.A. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res. 2004, 6:R170-R179.
13. Axelson M., Sjovall J., Gustafsson B.E., Setchell K.D. Soya - a dietary source of the non-steroidal oestrogen equol in man and animals. J. Endocrinol. 1984, 102:49-56.
14. Badger T.M., Ronis M.J., Hakkak R., Rowlands J.C., Korourian S. The health consequences of early soy consumption. J. Nutr. 2002, 132:559S-565S.
15. Badger T.M., Gilchrist J.M., Pivik R.T., Andres A., Shankar K., Chen J.R., Ronis M.J. The health implications of soy infant formula. Am. J. Clin. Nutr. 2009, 89:1668S-1672S.
16. Balk E., Chung M., Chew P., Ip S., Raman G., Kupelnick B., Tatsioni A., Sun Y., Devine D., Lau J. Effects of soy on health outcomes. Evid. Rep. Technol. Assess. 2005, (Summ):1-8.
17. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J.A., Nilsson S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol. Pharmacol. 1998, 54:105-112.
18. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 1995, 125:S777-S783.
19. Barrett J.R. Soy and children's health: a formula for trouble. Environ. Health Perspect. 2002, 110:A294-A296.
20. Barrett J.R. The science of soy: what do we really know?. Environ. Health Perspect. 2006, 114:A352-A358.
21. Bateman H.L., Patisaul H.B. Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology 2008, 29:988-997.
22. Bateman H.L., Patisaul H.B. Disrupted female reproductive physiology following neonatal exposure to phytoestrogens or estrogen specific ligands is associated with decreased GnRH activation and kisspeptin fiber density in the hypothalamus. Neurotoxicology 2008.
23. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo D.K., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
24. Beher D., Wu J., Cumine S., Kim K.W., Lu S.C., Atangan L., Wang M. Resveratrol is not a direct activator of SIRT 1 enzyme activity. Chem. Biol. Drug Des. 2009, 74:619-624.
25. Bennetts H.H.W., Underwood E.E.J. The oestrogenic effects of subterranean clover (trifolium subterraneum); uterine maintenance in the ovariectomised ewe on clover grazing. Aust. J. Exp. Biol. Med. Sci. 1951, 29:249-253.
26. Bennetts H.W., Underwood E.J., Shier F.L. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. Vet. J. 1946, 22:2.
27. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
28. Bernbaum J.C., Umbach D.M., Ragan N.B., Ballard J.L., Archer J.I., Schmidt-Davis H., Rogan W.J. Pilot studies of estrogen-related physical findings in infants. Environ. Health Perspect. 2008, 116:416-420.
29. Bhatia J., Greer F. Use of soy protein-based formulas in infant feeding. Pediatrics 2008, 121:1062-1068.
30. Bouker K.B., Hilakivi-Clarke L. Genistein: does it prevent or promote breast cancer?. Environ. Health Perspect. 2000, 108:701-708.
31. Boutin J.A. Minireview - Tyrosine protein kinase inhibition and cancer. Int. J. Biochem. Cell Biol. 1994, 26:1203-1226.
32. Braden A., Hart N., Lamberton J. Oestrogenic activity and metabolism of certain isoflavones in sheep. Aust. J. Agric. Res. 1967, 18:348-355.
33. Caldwell J.D., Johns J.M., Faggin B.M., Senger M.A., Pedersen C.A. Infusion of an oxytocin antagonist into the medial preoptic area prior to progesterone inhibits sexual receptivity and increases rejection in female rats. Horm. Behav. 1994, 28:288-302.
34. Cao Y., Calafat A.M., Doerge D.R., Umbach D.M., Bernbaum J.C., Twaddle N.C., Ye X., Rogan W.J. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J. Expo. Sci. Environ. Epidemiol. 2009, 19:223-234.
35. Casanova M., You L., Gaido K., Archibeque-Engle S., Janszen D., Heck H. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol. Sci. 1999, 51:236-244.
36. Cassidy A., Albertazzi P., Lise Nielsen I., Hall W., Williamson G., Tetens I., Atkins S., Cross H., Manios Y., Wolk A., Steiner C., Branca F. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 2006, 65:76-92.
37. Cederroth C.R., Auger J., Zimmermann C., Eustache F., Nef S. Soy, phyto-oestrogens and male reproductive function: a review. Int. J. Androl. 2009.
38. Chandrareddy A., Muneyyirci-Delale O., McFarlane S.I., Murad O.M. Adverse effects of phytoestrogens on reproductive health: a report of three cases. Complement Ther. Clin. Pract. 2008, 14:132-135.
39. Chang H.C., Churchwell M.I., Delclos K.B., Newbold R.R., Doerge D.R. Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J. Nutr. 2000, 130:1963-1970.
40. Chang E.C., Frasor J., Komm B., Katzenellenbogen B.S. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006, 147:4831-4842.
41. Chen A., Rogan W.J. Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu. Rev. Nutr. 2004, 24:33-54.
42. Chen S., Kao Y.C., Laughton C.A. Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase. J. Steroid Biochem. Mol. Biol. 1997, 61:107-115.
43. Chorazy P.A., Himelhoch S., Hopwood N.J., Greger N.G., Postellon D.C. Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics 1995, 96:148-150.
44. Chun O.K., Chung S.J., Song W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137:1244-1252.
45. Chun O.K., Chung S.J., Song W.O. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J. Am. Diet Assoc. 2009, 109:245-254.
46. Clarkson J., d'Anglemont de Tassigny X., Moreno A.S., Colledge W.H., Herbison A.E. Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge. J. Neurosci. 2008, 28:8691-8697.
47. Cooke G.M. A review of the animal models used to investigate the health benefits of soy isoflavones. J. AOAC Int. 2006, 89:1215-1227.
48. Cooke B., Hegstrom C., Villeneuve L., Breedlove S. Sexual differeniation of the vertebrate brain: principles and mechanisms. Front. Neuroendocrinol. 1998, 19:323-362.
49. Cooke B., Hegstrom C.D., Villeneuve L.S., Breedlove S.M. Sexual differentiation of the vertebrate brain: principles and mechanisms. Front. Neuroendocrinol. 1998, 19:323-362.
50. Crain D.A., Janssen S.J., Edwards T.M., Heindel J., Ho S.M., Hunt P., Iguchi T., Juul A., McLachlan J.A., Schwartz J., Skakkebaek N., Soto A.M., Swan S., Walker C., Woodruff T.K., Woodruff T.J., Giudice L.C., Guillette L.J. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil. Steril. 2008, 90:911-940.
51. D'Aloisio A.A., Baird D.D., DeRoo L.A., Sandler D.P. Association of intrauterine and early life exposures with diagnosis of uterine leiomyomata by age 35 in the sister study. Environ. Health Perspect. 2009.
52. Davis E.C., Shryne J.E., Gorski R.A. Structural sexual dimorphisms in the anteroventral periventricular nucleus of the rat hypothalamus are sensitive to gonadal steroids perinatally, but develop peripubertally. Neuroendocrinology 1996, 63:142-148.
53. Dechaud H., Ravard C., Claustrat F., Brac de la Perriere A. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 1999, 64:328-334.
54. Degen G.H., Janning P., Diel P., Bolt H.M. Estrogenic isoflavones in rodent diets. Toxicol. Lett. 2002, 128:145-157.
55. Delclos K.B., Newbold R. NTP toxicity report of reproductive dose range-finding study of genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats. Toxicol. Rep. Ser. 2007, 1-C2.
56. Demonty I., Lamarche B., Jones P.J. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr. Rev. 2003, 61:189-203.
57. Divi R.L., Chang H.C., Doerge D.R. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem. Pharmacol. 1997, 54:1087-1096.
58. Dodds E.C., Goldberg L., Larson W., Robinson R. Estrogenic activity of certain synthetic compounds. Nature 1938, 141:247.
59. Dodge J.A., Glasebrook A.L., Magee D.E., Phillips D.L., Sato M., Short L.L., Bryant H.U. Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. J. Steroid Biochem. Mol. Biol. 1996, 59:155-161.
60. Doerge D.R., Churchwell M.I., Chang H.C., Newbold R.R., Delclos K.B. Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reprod. Toxicol. 2001, 15:105-110.
61. Doerge D.R., Twaddle N.C., Banks E.P., Jefferson W.N., Newbold R.R. Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett. 2002, 184:21-27.
62. Doerge D.R., Twaddle N.C., Churchwell M.I., Newbold R.R., Delclos K.B. Lactational transfer of the soy isoflavone, genistein, in Sprague-Dawley rats consuming dietary genistein. Reprod. Toxicol. 2006, 21:307-312.
63. Draper C.R., Edel M.J., Dick I.M., Randall A.G., Martin G.G., Prince R.L. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr. 1997, 127:1795-1799.
64. Drummond A., Fuller P. The importance of ER{beta} signalling in ovarian function. J. Endocrinol. 2009.
65. Duncan A.M., Merz B.E., Xu X., Nagel T.C., Phipps W.R., Kurzer M.S. Soy isoflavones exert modest hormonal effects in premenopausal women. J. Clin. Endocrinol. Metab. 1999, 84:192-197.
66. Dunn A.J., Swiergiel A.H., Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann. NY Acad. Sci. 2004, 1018:25-34.
67. Elkind-Hirsch K., King J.C., Gerall A.A., Arimura A.A. The luteinizing hormone-releasing hormone (LHRH) system in normal and estrogenized neonatal rats. Brain Res. Bull. 1981, 7:645-654.
68. Enderlin C.A., Coleman E.A., Stewart C.B., Hakkak R. Dietary soy intake and breast cancer risk. Oncol. Nurs. Forum 2009, 36:531-539.
69. Engel S.M., Levy B., Liu Z., Kaplan D., Wolff M.S. Xenobiotic phenols in early pregnancy amniotic fluid. Reprod. Toxicol. 2006, 21:110-112.
70. Evans B.A., Griffiths K., Morton M.S. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 1995, 147:295-302.
71. Faber K.A., Hughes C.L. Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats. Reprod. Toxicol. 1993, 7:35-39.
72. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 2000, 52:513-556.
73. Farquharson R.G., Klopper A.I. A study of maternal, retroplacental and umbilical cord estradiol levels in term infants delivered by caesarean section. Eur. J. Obst. Gynecol. Reprod. Biol. 1984, 16:315-320.
74. Fisher J.S. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction 2004, 127:305-315.
75. Food and Drug Administration Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed. Regist. 1999, 64:57700-57733.
76. Food and Drug Administration, Health claims and qualified health claims; dietary lipids and cancer, soy protein and coronary heart diease, antioxidant vitamins and certain cancers, and selenium and certain cancers, Reevaluation, 2007.
77. Forsyth B.W., McCarthy P.L., Leventhal J.M. Problems of early infancy, formula changes, and mothers' beliefs about their infants. J. Pediatr. 1985, 106:1012-1017.
78. Foster W.G., Chan S., Platt L., Hughes C.L. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol. Lett. 2002, 129:199-205.
79. Franke A.A., Custer L.J. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J. Chromatogr. B: Biomed. Appl. 1994, 662:47-60.
80. Franke A.A., Custer L.J. Daidzein and genistein concentrations in human milk after soy consumption. Clin. Chem. 1996, 42:955-964.
81. Franke A.A., Custer L.J., Tanaka Y. Isoflavones in human breast milk and other biological fluids. Am. J. Clin. Nutr. 1998, 68:1466S-1473S.
82. Franke A.A., Halm B.M., Custer L.J., Tatsumura Y., Hebshi S. Isoflavones in breastfed infants after mothers consume soy. Am. J. Clin. Nutr. 2006, 84:406-413.
83. Freni-Titulaer L.L.W., Cordero J.J.F., Haddock L.L., Lebrón G.G., Martínez R.R., Mills J.J.L. Premature thelarche in Puerto Rico. A search for environmental factors. Am. J. Dis. Child. 1986, 140:1263-1267.
84. Fritz W.A., Coward L., Wang J., Lamartiniere C.A. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998, 19:2151-2158.
85. Giusti R.M., Iwamoto K., Hatch E.E. Diethylstilbestrol revisited: a review of the long-term health effects. Ann. Intern. Med. 1995, 122:778-788.
86. Goldman L.R., Newbold R., Swan S.H. Exposure to soy-based formula in infancy. JAMA 2001, 286:2402-2403.
87. Goodman M.T., Wilkens L.R., Hankin J.H., Lyu L.-C., Wu A.H., Kolonel L.N. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol. 1997, 146:294-306.
88. Goodman M.T., Shvetsov Y.B., Wilkens L.R., Franke A.A., Le Marchand L., Kakazu K.K., Nomura A.M., Henderson B.E., Kolonel L.N. Urinary phytoestrogen excretion, postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev. Res. (Phila Pa) 2009, 2:887-894.
89. Gorski R.A. Modification of ovulatory mechanisms by postnatal administration of estrogen to the rat. Am. J. Physiol. 1963, 205:842-844.
90. Gorski R.A. Sexual dimorphisms of the brain. J. Anim. Sci. 1985, 61(Suppl. 3):38-61.
91. Gorski R.A., Mennin S.P., Kubo K. The neural and hormonal bases of the reproductive cycle of the rat. Adv. Exp. Med. Biol. 1975, 54:115-153.
92. Gorski R.A., Gordon J.H., Shryne J.E., Southam A.M. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res. 1978, 143:333-346.
93. Gottsch M.L., Cunningham M.J., Smith J.T., Popa S.M., Acohido B.V., Crowley W.F., Seminara S., Clifton D.K., Steiner R.A. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004, 145:4073-4077.
94. Gruber J., Tang S.Y., Halliwell B. Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans. Ann. NY Acad. Sci. 2007, 1100:530-542.
95. Grumbach M.M. The neuroendocrinology of human puberty revisited. Horm. Res. 2002, 57(Suppl. 2):2-14.
96. Gu G.B., Simerly R.B. Projections of the sexually dimorphic anteroventral periventricular nucleus in the female rat. J. Comp. Neurol. 1997, 384:142-164.
97. Handa R.J., Weiser M.J., Zuloaga D.G. A role for the androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity. J. Neuroendocrinol. 2009, 21:351-358.
98. Hartley D.E., Edwards J.E., Spiller C.E., Alom N., Tucci S., Seth P., Forsling M.L., File S.E. The soya isoflavone content of rat diet can increase anxiety and stress hormone release in the male rat. Psychopharmacology (Berl) 2003, 167:46-53.
99. Helferich W.G., Andrade J.E., Hoagland M.S. Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 2008, 16:219-226.
100. Herbst A.L., Green T.H., Ulfelder H. Primary carcinoma of the vagina. An analysis of 68 cases. Am. J. Obstetr. Gynecol. 1970, 106:210-218.
101. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. New Engl. J. Med. 1971, 284:878-881.
102. Hertrampf T., Schleipen B., Offermanns C., Velders M., Laudenbach U., Diel P. Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats. Toxicol. Lett. 2009, 184:198-203.
103. Hodgson J.M., Puddey I.B., Beilin L.J., Mori T.A., Croft K.D. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J. Nutr. 1998, 128:728-732.
104. Hooper L., Ryder J.J., Kurzer M.S., Lampe J.W., Messina M.J., Phipps W.R., Cassidy A. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Human Reprod. Update 2009, 15:423-440.
105. Horn-Ross P.L., Barnes S., Lee V.S., Collins C.N., Reynolds P., Lee M.M., Stewart S.L., Canchola A.J., Wilson L., Jones K. Reliability and validity of an assessment of usual phytoestrogen consumption (United States). Cancer Causes Control 2006, 17:85-93.
106. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
107. Hsieh R.W., Rajan S.S., Sharma S.K., Guo Y., DeSombre E.R., Mrksich M., Greene G.L. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. J. Biol. Chem. 2006, 281:17909-17919.
108. Hutchins A.M., Slavin J.L., Lampe J.W. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Ass. 1995, 95:545-551.
109. Iguchi T., Takasugi N. Polyovular follicles in the ovary of immature mice exposed prenatally to diethylstilbestrol. Anat. Embryol. (Berl) 1986, 175:53-55.
110. Iguchi T., Takasugi N., Bern H.A., Mills K.T. Frequent occurrence of polyovular follicles in ovaries of mice exposed neonatally to diethylstilbestrol. Teratology 1986, 34:29-35.
111. Iguchi T., Fukazawa Y., Uesugi Y., Takasugi N. Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol. Reprod. 1990, 43:478-484.
112. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of Bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
113. Irvine C.H., Shand N., Fitzpatrick M.G., Alexander S.L. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas. Am. J. Clin. Nutr. 1998, 68:1462S-1465S.
114. Irwig M.S., Fraley G.S., Smith J.T., Acohido B.V., Popa S.M., Cunningham M.J., Gottsch M.L., Clifton D.K., Steiner R.A. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology 2004, 80:264-272.
115. Jacobs A., Wegewitz U., Sommerfeld C., Grossklaus R., Lampen A. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - a systematic review. Mol. Nutr. Food Res. 2009, 53:1084-1097.
116. Jefferson W.N., Couse J.F., Padilla-Banks E., Korach K.S., Newbold R.R. Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol. Reprod. 2002, 67:1285-1296.
117. Jefferson W.N., Padilla-Banks E., Clark G., Newbold R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 777:179-189.
118. Jefferson W.N., Padilla-Banks E., Newbold R.R. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol. Reprod. 2005, 73:798-806.
119. Jefferson W., Newbold R., Padilla-Banks E., Pepling M. Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol. Reprod. 2006, 74:161-168.
120. Jefferson W.N., Padilla-Banks E., Goulding E.H., Lao S.P., Newbold R.R., Williams C.J. Neonatal exposure to genistein disrupts ability of female mouse reproductive tract to support preimplantation embryo development and implantation. Biol. Reprod. 2009, 80:425-431.
121. Joensen U.N., Jorgensen N., Rajpert-De Meyts E., Skakkebaek N.E. Testicular dysgenesis syndrome and Leydig cell function. Basic Clin. Pharmacol. Toxicol. 2008, 102:155-161.
122. Johns P., Dowlati L., Wargo W. Determination of isoflavones in ready-to-feed soy-based infant formula. J. AOAC Int. 2003, 86:72-78.
123. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., Wang Z.Y. Involvement of estrogen receptor variant ER-{alpha}36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 2010.
124. Kauffman A.S. Sexual differentiation and the Kiss1 system: hormonal and developmental considerations. Peptides 2009, 30:83-93.
125. Kauffman A.S., Clifton D.K., Steiner R.A. Emerging ideas about kisspeptin-GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci. 2007, 30:504-511.
126. Kenny A.M., Mangano K.M., Abourizk R.H., Bruno R.S., Anamani D.E., Kleppinger A., Walsh S.J., Prestwood K.M., Kerstetter J.E. Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial. Am. J. Clin. Nutr. 2009, 90:234-242.
127. Kim J. Protective effects of Asian dietary items on cancers - soy and ginseng. Asian Pac. J. Cancer Prev. 2008, 9:543-548.
128. Koehler K.F., Helguero L.A., Haldosen L.A., Warner M., Gustafsson J.A. Reflections on the discovery and significance of estrogen receptor beta. Endocr. Rev. 2005, 26:465-478.
129. Kouki T., Kishitake M., Okamoto M., Oosuka I., Takebe M., Yamanouchi K. Effects of neonatal treatment with phytoestrogens, genistein and daidzein, on sex difference in female rat brain function: estrous cycle and lordosis. Horm. Behav. 2003, 44:140-145.
130. Kubo K., Arai O., Omura M., Watanabe R., Ogata R., Aou S. Low dose effects of Bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci. Res. 2003, 45:345-356.
131. Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93:5925-5930.
132. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Häggblad J., Hilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138:863-870.
133. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van Der Saag P.T., Van Der Berg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998, 139:4252-4263.
134. Kurzer M.S. Phytoestrogen supplement use by women. J. Nutr. 2003, 133:1983S-1986S.
135. Kurzer M.S. Soy consumption for reduction of menopausal symptoms. Inflammopharmacology 2008, 16:227-229.
136. Kurzer M.S., Xu X. Dietary phytoestrogens. Annu. Rev. Nutr. 1997, 17:353-381.
137. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
138. Lakind J.S., Naiman D.Q. Daily intake of Bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. J. Expo. Sci. Environ. Epidemiol. 2010.
139. Lampe J.W. Is equol the key to the efficacy of soy foods?. Am. J. Clin. Nutr. 2009, 89:1664S-1667S.
140. Lampe J., Karr S., Hutchins A., Slavin J. Urinary equol excretion with a soy challenge: influence of habitual diet. PSEBM 1998, 217:335-339.
141. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects on breast-cancer risk in Singapore. Lancet 1991, 337:1197-1200.
142. Lee Y.B., Lee H.J., Sohn H.S. Soy isoflavones and cognitive function. J. Nutr. Biochem. 2005, 16:641-649.
143. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA 2008, 105:3374-3379.
144. Legette L.L., Martin B.R., Shahnazari M., Lee W.H., Helferich W.G., Qian J., Waters D.J., Arabshahi A., Barnes S., Welch J., Bostwick D.G., Weaver C.M. Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats. J. Nutr. 2009, 139:1908-1913.
145. Lephart E.D., West T., Weber K.S., Rhees R.W., Setchell K., Adlercreutz H., Lund T. Neurobehavioral effects of dietary soy phytoestrogens. Neurotoxicol. Teratol. 2002, 24:5-16.
146. Lephart E.D., Setchell K.D., Lund T.D. Phytoestrogens: hormonal action and brain plasticity. Brain Res. Bull. 2005, 65:193-198.
147. Levin E.R. Membrane oestrogen receptor alpha signalling to cell functions. J. Physiol. 2009, 587:5019-5023.
148. Lewis R.W., Brooks N., Milburn G.M., Soames A., Stone S., Hall M., Ashby J. The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol. Sci. 2003, 71:74-83.
149. Li B., Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol. Pharm. Bull. 2003, 26:780-786.
150. Lindzey J., Korach K.S. Developmental and physiological effects of estrogen receptor gene disruption in mice. Trends Endocrinol. Metab. 1997, 8:137-145.
151. Linford N.J., Dorsa D.M. 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002, 67:1029-1040.
152. Liu J., Ho S.C., Su Y.X., Chen W.Q., Zhang C.X., Chen Y.M. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 2009, 44:948-953.
153. Lund T., Rhees R., Setchell K., Lephart E. Altered sexually dimorphic nucleus of the preoptic area (SDN-POA) volume in adult Long-Evans rats by dietary soy phytoestrogens. Brain Res. 2001, 914:92-99.
154. Lund T.D., Rovis T., Chung W.C., Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
155. Lurje G., Lenz H.J., FR E.G. EGFR signaling and drug discovery. Oncology 2009, 77:400-410.
156. E. Lydeking-Olsen, J.-B.E. Jensen, K.D.R. Setchell, M. Daamhus, T.H. Jensen, Isoflavone-rich soymilk prevents bone-loss in the lumbar spine of postmenopasual women. A 2 year study, J. Nutr. 132 (2002) 581S (abstract).
157. Maggi A., Ciana P., Belcredito S., Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol. 2004, 66:291-313.
158. Makela S., Savolainen H., Aavik E., Myllarniemi M., Strauss L., Taskinen E., Gustafsson J.A., Hayry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. USA 1999, 96:7077-7082.
159. Manas E.S., Xu Z.B., Unwalla R.J., Somers W.S. Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure 2004, 12:2197-2207.
160. Markiewicz L., Garey J., Adlercreutz H., Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 1993, 45:399-405.
161. Maskarinec G., Williams A.E., Inouye J.S., Stanczyk F.Z., Franke A.A. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol. Biomarkers Prev. 2002, 11:195-201.
162. Maskarinec G., Williams A.E., Inouye J.S., Stanczyk F.Z., Franke A.A. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol. Biomarkers Prevent. 2002, 11:195-201.
163. Maskarinec G., Takata Y., Franke A.A., Williams A.E., Murphy S.P. A 2-year soy intervention in premenopausal women does not change mammographic densities. J. Nutr. 2004, 134:3089-3094.
164. Massart F., Parrino R., Seppia P., Federico G., Saggese G. How do environmental estrogen disruptors induce precocious puberty?. Minerva. Pediatr. 2006, 58:247-254.
165. Masutomi N., Shibutani M., Takagi H., Uneyama C., Takahashi N., Hirose M. Impact of dietary exposure to methoxychlor, genistein, or diisononyl phthalate during the perinatal period on the development of the rat endocrine/reproductive systems in later life. Toxicology 2003, 192:149-170.
166. Mathey J., Mardon J., Fokialakis N., Puel C., Kati-Coulibaly S., Mitakou S., Bennetau-Pelissero C., Lamothe V., Davicco M.J., Lebecque P., Horcajada M.N., Coxam V. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteopor. Int. 2007, 18:671-679.
167. McLachlan J.A., Newbold R.R., Bullock B.C. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 1980, 40:3988-3999.
168. McLachlan J.A., Newbold R.R., Shah H.C., Hogan M.D., Dixon R.L. Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil. Steril. 1982, 38:364-371.
169. Messina M.J., Persky V., Setchell K.D., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 1994, 21:113-131.
170. Messina M., Gardner C., Barnes S. Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth international symposium on the role of soy in preventing and treating chronic disease. J. Nutr. 2002, 132:547S-551S.
171. Messina M., Nagata C., Wu A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 2006, 55:1-12.
172. Micevych P., Dominguez R. Membrane estradiol signaling in the brain. Front. Neuroendocrinol. 2009, 30:315-327.
173. Micevych P., Kuo J., Christensen A. Physiology of membrane oestrogen receptor signalling in reproduction. J. Neuroendocrinol. 2009, 21:249-256.
174. Moore T.O., Karom M., O'Farrell L. The neurobehavioral effects of phytoestrogens in male Syrian hamsters. Brain Res. 2004, 1016:102-110.
175. Mortensen A., Kulling S.E., Schwartz H., Rowland I., Ruefer C.E., Rimbach G., Cassidy A., Magee P., Millar J., Hall W.L., Kramer Birkved F., Sorensen I.K., Sontag G. Analytical and compositional aspects of isoflavones in food and their biological effects. Mol. Nutr. Food Res. 2009, 53(Suppl. 2):S266-S309.
176. Murkies A., Lombard C., Strauss B., Wilcox G., Burger H., Morton M. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1995, 21:189-195.
177. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., Helferich W.G., Katzenellenbogen J.A. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 2004, 12:1559-1567.
178. Nagao T., Yoshimura S., Saito Y., Nakagomi M., Usumi K., Ono H. Reproductive effects in male and female rats of neonatal exposure to genistein. Reprod. Toxicol. 2001, 15:399-411.
179. Nagata C., Takatsuka N., Inaba S., Kawakami N., Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J. Natl. Cancer Inst. 1998, 90:1830-1835.
180. Nagata C., Iwasa S., Shiraki M., Ueno T., Uchiyama S., Urata K., Sahashi Y., Shimizu H. Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan). Cancer Causes Control 2006, 17:1107-1113.
181. Navarro V.M., Fernandez-Fernandez R., Castellano J.M., Roa J., Mayen A., Barreiro M.L., Gaytan F., Aguilar E., Pinilla L., Dieguez C., Tena-Sempere M. Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J. Physiol. 2004, 561:379-386.
182. Nestel P.J., Pomeroy S., Kay S., Komesaroff P., Behrsing J., Cameron J.D., West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 1999, 84:895-898.
183. Newbold R.R. Prenatal exposure to diethylstilbestrol (DES). Fertil. Steril. 2008, 89:e55-e56.
184. Newbold R.R., Banks E.P., Bullock B., Jefferson W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 2001, 61:4325-4328.
185. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., Tsubura A. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod. Toxicol. 2004, 18:803-811.
186. North K., Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int. 2000, 85:107-113.
187. NTP Multigenerational Reproductive Study of Genistein (CAS No. 446-72-0) in Sprague-Dawley Rats (Feed Study), Natl. Toxicol. Program Tech. Rep. Ser. (2008) 1-266.
188. Oakley A.E., Clifton D.K., Steiner R.A. Kisspeptin signaling in the brain. Endocr. Rev. 2009, 30:713-743.
189. Ogawa S., Taylor J.A., Lubahn D.B., Korach K.S., Pfaff D.W. Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. Neuroendocrinology 1996, 64:467-470.
190. Ogawa S., Eng V., Taylor J., Lubahn D.B., Korach K.S., Pfaff D.W. Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology 1998, 139:5070-5081.
191. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12] Ha-ras-transformed NIH 3T 3 cells. Biochem. Biophys. Res. Commun. 1988, 157:183-189.
192. Oseni T., Patel R., Pyle J., Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008, 74:1656-1665.
193. Oseni T., Patel R., Pyle J., Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008, 74:1656-1665.
194. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., Griffith D., Griffor M., Loulakis P., Pabst B., Qiu X., Stockman B., Thanabal V., Varghese A., Ward J., Withka J., Ahn K., RT S. SRT 2183, SRT 1460, and resveratrol are not direct activators of SIRT 1. J. Biol. Chem. 1720, 285(2010):8340-8351.
195. Padilla-Banks E., Jefferson W.N., Newbold R.R. Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor levels. Endocrinology 2006, 147:4871-4882.
196. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., Tao L., Kannan K. Maternal Bisphenol-A levels at delivery: a looming problem?. J. Perinatol. 2008, 28:258-263.
197. Palmlund I. Exposure to a xenoestrogen before birth: the diethylstilbestrol experience. J. Psychosomatic Obstetrics Gynaecol. 1996, 17:71-84.
198. Parent A.S., Teilmann G., Juul A., Skakkebaek N.E., Toppari J., Bourguignon J.P. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr. Rev. 2003, 24:668-693.
199. Park D., Huang T., Frishman W.H. Phytoestrogens as cardioprotective agents. Cardiol. Rev. 2005, 13:13-17.
200. Patchev A.V., Gotz F., Rohde W. Differential role of estrogen receptor isoforms in sex-specific brain organization. FASEB J. 2004, 18:1568-1570.
201. Patisaul H.B. Phytoestrogen action in the adult and developing brain. J. Neuroendocrinol. 2005, 17:57-64.
202. Patisaul H.B., Polston E.K. Influence of endocrine active compounds on the developing rodent brain. Brain Res. Rev. 2008, 57:352-362.
203. Patisaul H.B., Whitten P.L., Young L. Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17β-estradiol and the phytoestrogen, coumestrol. Brain Res: Mol. Brain Res. 1999, 67:165-171.
204. Patisaul H.B., Dindo M., Whitten P.L., Young L.J. Soy isoflavone supplements antagonize reproductive behavior and ERα- and ERβ-dependent gene expression in the brain. Endocrinology 2001, 142:2946-2952.
205. Patisaul H.B., Melby M., Whitten P.L., Young L.J. Genistein affects ERβ- but not ERα-dependent gene expression in the hypothalamus. Endocrinology 2002, 143:2189-2197.
206. Patisaul H.B., Scordalakes E.M., Young L.J., Rissman E.F. Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor beta in the female mouse hypothalamus. J. Neuroendocrinol. 2003, 15:787-793.
207. Patisaul H.B., Luskin J.R., Wilson M.E. A soy supplement and tamoxifen inhibit sexual behavior in female rats. Horm. Behav. 2004, 45:270-277.
208. Patisaul H.B., Fortino A.E., Polston E.K. Differential disruption of nuclear volume and neuronal phenotype in the preoptic area by neonatal exposure to genistein and Bisphenol-A. Neurotoxicology 2007, 28:1-12.
209. Patisaul H.B., Todd K.L., Mickens J.A., Adewale H.B., PPT Impact of neonatal exposure to the ERα agonist Bisphenol-A or phytoestrogens on hypothalamic kisspeptin fiber density in male and female rats. Neurotoxicology 2009, 30(3):350-357.
210. Peeters P.H., Slimani N., van der Schouw Y.T., Grace P.B., Navarro C., Tjonneland A., Olsen A., Clavel-Chapelon F., Touillaud M., Boutron-Ruault M.C., Jenab M., Kaaks R., Linseisen J., Trichopoulou A., Trichopoulos D., Dilis V., Boeing H., Weikert C., Overvad K., Pala V., Palli D., Panico S., Tumino R., Vineis P., Bueno-de-Mesquita H.B., van Gils C.H., Skeie G., Jakszyn P., Hallmans G., Berglund G., Key T.J., Travis R., Riboli E., Bingham S.A. Variations in plasma phytoestrogen concentrations in European adults. J. Nutr. 2007, 137:1294-1300.
211. Pelissero C., Lenczowski M., Chinzi D., Davail-Cuisset B., Sumpter J., Fostier A. Effects of flavonoids on aromatase activity, and in vitro study. J. Steroid Biochem. Mol. Biol. 1996, 57:215-223.
212. Pepling M.E., Spradling A.C. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev. Biol. 2001, 234:339-351.
213. Perez S.E., Chen E.Y., Mufson E.J. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res. Dev. Brain Res. 2003, 145:117-139.
214. Pfaff D. Drive 1999, MIT Press, Cambridge, MA.
215. Pfitscher A., Reiter E., Jungbauer A. Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J. Steroid Biochem. Mol. Biol. 2008, 112:87-94.
216. Piontek M., Hangels K.J., Porschen R., Strohmeyer G. Anti-proliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res. 1993, 13:2119-2123.
217. Piotrowska E., Jakobkiewicz-Banecka J., Wegrzyn G. Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytother. Res. 2009.
218. Polston E.K., Simerly R.B. Ontogeny of the projections from the anteroventral periventricular nucleus of the hypothalamus in the female rat. J. Comp. Neurol. 2006, 495:122-132.
219. Polston E.K., Gu G., Simerly R.B. Neurons in the principal nucleus of the bed nuclei of the stria terminalis provide a sexually dimorphic GABAergic input to the anteroventral periventricular nucleus of the hypothalamus. Neuroscience 2004, 123:793-803.
220. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., Erdman J.W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 1998, 68:1375S-1379S.
221. Ravindranath M.H., Muthugounder S., Presser N., Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv. Exp. Med. Biol. 2004, 546:121-165.
222. Register T.C., Jayo M.J., Anthony M.S. Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J. Clin. Endocrinol. Metabol. 2003, 88:4362-4370.
223. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
224. Rissman E.F. Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/Yang. J. Neuroendocrinol. 2008, 20:873-879.
225. Rissman E.F., Wersinger S.R., Taylor J.A., Lubahn D.B. Estrogen receptor function as revealed by knockout by knockout studies: neuroendocrine and behavioral aspects. Horm. Behav. 1997, 31:232-243.
226. Roa J., Vigo E., Castellano J.M., Navarro V.M., Fernandez-Fernandez R., Casanueva F.F., Dieguez C., Aguilar E., Pinilla L., Tena-Sempere M. Hypothalamic expression of KiSS-1 system and gonadotropin-releasing effects of kisspeptin in different reproductive states of the female Rat. Endocrinology 2006, 147:2864-2878.
227. Robb E.L., Page M.M., Wiens B.E., Stuart J.A. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 2008, 367:406-412.
228. Rolwand I., Wiseman H., Sanders T., Adlercreutz H., Bowey E. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer 2000, 36:27-32.
229. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
230. Routledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J. Biol. Chem. 2000, 275:35986-35993.
231. Rozman K.K., Bhatia J., Calafat A.M., Chambers C., Culty M., Etzel R.A., Flaws J.A., Hansen D.K., Hoyer P.B., Jeffery E.H., Kesner J.S., Marty S., Thomas J.A., Umbach D. NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res. B Dev. Reprod. Toxicol. 2006, 77:485-638.
232. Rubin M.M. Antenatal exposure to DES: lessons learned.future concerns. Obstetr. Gynecol. Survey 2007, 62:548-555.
233. Ruiz-Larrea M.B., Mohan A.R., Paganga G., Miller N.J., Bolwell G.P., Rice-Evans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 1997, 26:63-70.
234. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044.
235. Santell R.C., Chang Y.C., Nair M.G., Helferich W.G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J. Nutr. 1997, 127:263-269.
236. Scallet A.C., Wofford M., Meredith J.C., Allaben W.T., Ferguson S.A. Dietary exposure to genistein increases vasopressin but does not alter beta-endorphin in the rat hypothalamus. Toxicol. Sci. 2003, 72:296-300.
237. Scallet A.C., Divine R.L., Newbold R.R., Delclos K.B. Increased volume of the calbindin D28k-labeled sexually dimorphic hypothalamus in genistein and nonylphenol-treated male rats. 1. Toxicol. Sci. 2004, 82:570-576.
238. Schairer C., Lubin J., Troisi R., Sturgeon S., Brinton L., Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000, 283:485-491.
239. Schmidt S., Degen G.H., Seibel J., Hertrampf T., Vollmer G., Diel P. Hormonal activity of combinations of genistein, Bisphenol A and 17beta-estradiol in the female Wistar rat. Arch. Toxicol. 2006, 80:839-845.
240. Schoental R. Precocious sexual development in Puerto Rico and oestrogenic mycotoxins (zearalenone). Lancet 1983, 1:537.
241. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent Bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110:A703-A707.
242. Schwartz H., Sontag G., Plumb J. Inventory of phytoestrogen databases. Food Chem. 2009, 113:736-747.
243. Senti F. Soy protein foods in U.S. assistance programs. J. Am. Oil Chem. Soc. 1974, 51:138A-140A.
244. Setchell K.D., Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 2003, 78:593S-609S.
245. Setchell K.D.R., Welsh M.B. High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet electrochemical and thermospray mass spectrometric detection. J. Chromatogr. 1987, A 386:315-323.
246. Setchell K.K.D., Gosselin S.S.J., Welsh M.M.B., Johnston J.J.O., Balistreri W.W.F., Kramer L.L.W., Dresser B.B.L., Tarr M.M.J. Dietary estrogens - a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 1987, 93:225-233.
247. Setchell K.D., Zimmer-Nechemias L., Cai J., Heubi J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997, 350:23-27.
248. Setchell K.D.R., Zimmer-Nechemias L., Cai J., Heubi J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997, 350:23-27.
249. Setchell K.D., Zimmer-Nechemias L., Cai J., Heubi J.E. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am. J. Clin. Nutr. 1998, 68:1453S.
250. Setchell K.D., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., Heubi J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 2001, 131:1362S-1375S.
251. Setchell K.D., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J. Nutr. 2002, 132:3577-3584.
252. Setchell K.D., Brown N.M., Desai P.B., Zimmer-Nechimias L., Wolfe B., Jakate A.S., Creutzinger V., Heubi J.E. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr. 2003, 133:1027-1035.
253. Sharpe R.M., Martin B., Morris K., Greig I., McKinnell C., McNeilly A.S., Walker M. Infant feeding with soy formula milk: effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity. Hum. Reprod. 2002, 17:1692-1703.
254. Shen W., Stearns V. Treatment strategies for hot flushes. Expert. Opin. Pharmacother. 2009, 10:1133-1144.
255. Shu X.O., Zheng Y., Cai H., Gu K., Chen Z., Zheng W., Lu W. Soy food intake and breast cancer survival. JAMA 2009, 302:2437-2443.
256. Shughrue P.L., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor α and β mRNA in the rat central nervous system. J. Comp. Neurol. 1997, 388:507-525.
257. Shughrue P., Lane M., Scrimo P., Merchenthaler I. Comparative distribution of estrogen receptor-α (ERα) and β (ERβ) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998, 63:498-504.
258. Simerly R.B. Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Annu. Rev. Neurosci. 2002, 25:507-536.
259. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 1990, 294:76-95.
260. Simon N.G., Kaplan J.R., Hu S., Register T.C., Adams M.R. Increased aggressive behavior and decreased affiliative behavior in adult male monkeys after long-term consumption of diets rich in soy protein and isoflavones. Horm. Behav. 2004, 45:278-284.
261. Sirtori C.R., Arnoldi A., Johnson S.K. Phytoestrogens: end of a tale?. Ann. Med. 2005, 37:423-438.
262. Smith O.W. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am. J. Obst. Gynecol. 1948, 56:821-834.
263. Smith J.T., Clifton D.K., Steiner R.A. Regulation of the neuroendocrine reproductive axis by kisspeptin-GPR54 signaling. Reproduction 2006, 131:623-630.
264. Smith J.T., Popa S.M., Clifton D.K., Hoffman G.E., Steiner R.A. Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J. Neurosci. 2006, 26:6687-6694.
265. Soyfoods Associations of North America, Soyfood Sales and Trends, 2009.
266. Speroff L. Alternative therapies for postmenopausal women. Int. J. Fertil. Womens Med. 2005, 50:101-114.
267. Stricker R., Eberhart R., Chevailler M.C., Quinn F.A., Bischof P. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin. Chem. Lab. Med. 2006, 44:883-887.
268. Strom B.L., Schinnar R., Ziegler E.E., Barnhart K.T., Sammel M.D., Macones G.A., Stallings V.A., Drulis J.M., Nelson S.E., Hanson S.A. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 2001, 286:807-814.
269. Suzuki A., Sugihara A., Uchida K., Sato T., Ohta Y., Katsu Y., Watanabe H., Iguchi T. Developmental effects of perinatal exposure to Bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod. Toxicol. 2002, 16:107-116.
270. Swan S.H., Elkin E.P., Fenster L. The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environ. Health Perspect. 2000, 108:961-966.
271. Tan K.A., Walker M., Morris K., Greig I., Mason J.I., Sharpe R.M. Infant feeding with soy formula milk: effects on puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood. Human Reprod. 2006, 21:896-904.
272. Taylor C.K., Levy R.M., Elliott J.C., Burnett B.P. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr. Rev. 2009, 67:398-415.
273. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
274. Thomas J.M., Lutz S.F. Soy protein lowers fat and saturated fat in school lunch beef and pork entrees. J. Am. Diet. Assoc. 2001, 101:461-463.
275. Todaka E., Sakurai K., Fukata H., Miyagawa H., Uzuki M., Omori M., Osada H., Ikezuki Y., Tsutsumi O., Iguchi T., Mori C. Fetal exposure to phytoestrogens - the difference in phytoestrogen status between mother and fetus. Environ. Res. 2005, 99:195-203.
276. Tomar R.S., Shiao R. Early life and adult exposure to isoflavones and breast cancer risk. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2008, 26:113-173.
277. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society, Menopause 11 (2004) 11-33.
278. Trock B.J., Hilakivi-Clarke L., Clarke R. Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 2006, 98:459-471.
279. Tuohy P.G. Soy infant formula and phytoestrogens. J. Paediatr. Child Health 2003, 39:401-405.
280. UK-Committee-on-Toxicity, Phytoestrogens and Health, Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, London, 2003.
281. United States Department of Agriculture (Agricultural Research Service), Database for the Isoflavone Content of Selected Foods, Release 2.0, 2008.
282. U.S. Board, 16th Annual Survey: Consumer Attitudes About Nutrition, 2009.
283. Valentin-Blasini L., Blount B.C., Caudill S.P., Needham L.L. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J. Expos. Anal. Environ. Epidemiol. 2003, 13:276-282.
284. van Pelt A.M., de Rooij D.G., van der Burg B., van der Saag P.T., Gustafsson J.A., Kuiper G.G. Ontogeny of estrogen receptor-beta expression in rat testis. Endocrinology 1999, 140:478-483.
285. Vasudevan N., Pfaff D.W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 2008, 29:238-257.
286. Verheus M., van Gils C.H., Keinan-Boker L., Grace P.B., Bingham S.A., Peeters P.H. Plasma phytoestrogens and subsequent breast cancer risk. J. Clin. Oncol. 2007, 25:648-655.
287. Verkasalo P.K., Appleby P.N., Allen N.E., Davey G., Adlercreutz H., Key T.J. Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br. J. Nutr. 2001, 86:415-421.
288. Wallen K. Hormonal influences on sexually differentiated behavior in nonhuman primates. Front. Neuroendocrinol. 2005, 26:7-26.
289. Wang C., Makela T., Hase T.A., Adlercreutz C.H.T., Kurzer M.S. Lignans and isoflavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Mol. Biol. 1994, 50:205-212.
290. Wang T.T., Sathyamoorthy N., Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996, 17:271-275.
291. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 2005, 336:1023-1027.
292. Warri A., Saarinen N.M., Makela S., Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer 2008, 98:1485-1493.
293. Whitten P.L., Patisaul H.B. Cross-species and interassay comparisons of phytoestrogen action. Environ. Health Perspect. 2001, 109:5-23.
294. Whitten P.L., Kudo S., Okubo K.K. Isoflavonoids. Handbook of Plant and Fungal Toxicants 1997, 117-137. CRC Press, Boca Raton. J.P.F. D'Mello (Ed.).
295. Winter J.S.D., Hughes I.A., Reyes F.I., Faiman C. Pituitary-gonadal relations in infancy: patterns of serum gonadal steroid concentrations in man from birth to two years of age. J. Clin. Endocrinol. Metabol. 1976, 42:679-686.
296. Witt D.M., Insel T.R. A selective oxytocin antagonist attenuates progesterone facilitation of female sexual behavior. Endocrinology 1991, 128:3269-3276.
297. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
298. Wu A.H., Stanczyk F.Z., Hendrich S., Murphy P.A., Zhang C., Wan P., Pike M.C. Effects of soy foods on ovarian function in premenopausal women. Br. J. Cancer 2000, 82:1879-1886.
299. Wu A.H., Yu M.C., Tseng C.C., Pike M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 2008, 98:9-14.
300. Wu A.H., Yu M.C., Tseng C.C., Pike M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 2008, 98:9-14.
301. Yamori Y., Moriguchi E.H., Teramoto T., Miura A., Fukui Y., Honda K.I., Fukui M., Nara Y., Taira K., Moriguchi Y. Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J. Am. Coll. Nutr. 2002, 21:560-563.
302. Ye S.F., Saga I., Ichimura K., Nagai T., Shinoda M., Matsuzaki S. Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats. Endocr. Regulat. 2003, 37:145-152.
303. Ye X., Kuklenyik Z., Needham L.L., Calafat A.M. Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2006, 831:110-115.
304. Young L.J., Wang Z., Donaldson R., Rissman E.F. Estrogen receptor α is essential for induction of oxytocin receptor by estrogen. NeuroReport 1998, 9:933-936.
305. Zhang J.Q., Cai W.Q., Zhou de S., Su B.Y. Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res. 2002, 935:73-80.
306. Zhang C., Ho S.C., Lin F., Cheng S., Fu J., Chen Y. Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci. 2009.
307. Zoppi G., Guandalini S. The story of soy formula feeding in infants: a road paved with good intentions. J. Pediatric Gastroenterol. Nutr 1999, 28:541-543.
308. Zung A., Glaser T., Kerem Z., Zadik Z. Breast development in the first 2 years of life: an association with soy-based infant formulas. J. Pediatric Gastroenterol. Nutr. 2008, 46:191-195.